Roche to Develop Companion Diagnostic Test for Dalcetrapi
Roche, a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, has signed an agreement to develop a […]
Say something
Tags: Business/Finance, Cardiovascular disease, CEO, CHF, CHUGAI PHARMACEUTICAL CO. LTD., clinical trial, DalCor Pharmaceuticals, FDA, GENENTECH INC., Head, Health/Medical/Pharmaceuticals, Hoffmann-La Roche, Japan, leader, M&A, majority shareholder, Paul Brown, personalized healthcare, Pharmaceutical industry in the People's Republic of China, Pharmaceutical sciences, pharmaceuticals, Pharmacology, research, research-focused healthcare, Robert McNeil, Roche, Roche Diagnostics, Roche Holding Ltd, Roche Molecular Diagnostics, science, United States
News- feb 2010
Biodesign programme to be launched in SingaporeStanford University Biodesign Program and Singapore’s Agency for Science, Technology & Research, and the […]
Philips and Definiens Sign Memorandum of Understanding to Join Forces in Digital Pathology
Royal Philips Electronics and Definiens, a Germany-based company specializing in image analysis solutions, announced that they have signed a memorandum of understanding to jointly develop and market clinical decision support solutions for digital pathology.
-
-
Flipkart Health+ App Launched
06-04-2022
